Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 22, 2016
Implementation of the Kids-CAT in clinical settings: a newly developed computer-adaptive test to facilitate the assessment of patient-reported outcomes of children and adolescents in clinical practice in GermanyD Barthel, K I Fischer, S Nolte, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 11, 2016
The validation of a computer-adaptive test (CAT) for assessing health-related quality of life in children and adolescents in a clinical sample: study design, methods and first results of the Kids-CAT studyD Barthel, C Otto, S Nolte, et al.The Journal of Clinical Investigation|January 15, 1997
Quasiperiodicity and chaos in cardiac fibrillationA Garfinkel, P S Chen, D O Walter, et al.Fundamental & Clinical Pharmacology|January 3, 2025
A novel naphthylchalcone ([E]-4-(3-[naphthalen-2-yl]-3-oxoprop-1-en-1-yl) induces intrinsic and extrinsic apoptosis in human acute leukemia cell linesAmanda V Jacques, Natália M Stefanes, Laura O Walter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2020
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid TumorsRaffit Hassan, George R Blumenschein, Kathleen N Moore, et al.British Journal of Cancer|May 3, 2017
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignanciesRastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 23, 2022
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion studyAlessandro D Santin, Ignace Vergote, Antonio González-Martín, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2015
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction studyW Kreuz, C Escuriola Ettingshausen, V Vdovin, et al.Molecular Cancer Therapeutics|April 12, 2014
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparingRobert Tjin Tham Sjin, Kwangho Lee, Annette O Walter, et al.The Lancet. Oncology|March 31, 2022
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trialHedy L Kindler, Silvia Novello, Alessandra Bearz, et al.Pageof 8